Untitled document

National Health (Pharmaceutical Benefits Scheme ‑Exempt items ‑ Section 84AH) Determination 2017 (PB 81 of 2017)

made under section 84AH of the

National Health Act 1953

Compilation No. 5

Compilation date:   1 November 2018

Includes amendments up to:            PB 97 of 2018

Registered:   12 November 2018

About this compilation

This compilation

This is a compilation of the National Health (Pharmaceutical Benefits Scheme -Exempt items - Section 84AH) Determination 2017 (PB 81 of 2017) that shows the text of the law as amended and in force on 1 November 2018 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

1............ Name of Instrument....................................................................................................... 1

4............ Authority....................................................................................................................... 1

5............ Definitions..................................................................................................................... 1

6............ Exempt items................................................................................................................. 1

Schedule  2

Endnotes4

Endnote 1—About the endnotes  4

Endnote 2—Abbreviation key  5

Endnote 3—Legislation history  6

Endnote 4—Amendment history  7

1  Name of Instrument

(1)  This instrument is the National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017.

(2)  This instrument may also be cited as PB 81 of 2017.

4  Authority

This Determination is made under section 84AH of the National Health Act 1953 (the Act).

5  Definitions

In this Determination:

pharmaceutical item has the meaning given by section 84AB of the Act.

Note:          Terms used in this Determination have the same meaning as in the Act – see section 13 of the Legislation Act 2003. These terms include:

•   listed drug

•   form

•   manner of administration

6  Exempt items

The pharmaceutical items identified in the Schedule are exempt from statutory price reductions and price disclosure requirements under Division 3A and 3B of Part VII of the Act.

Schedule

Listed Drug	Form (strength, type, size, etc.)	Manner of administration
Amisulpride	Oral solution 100 mg per mL, 60 mL	Oral
Amoxicillin	Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL	Oral
Artemether with Lumefantrine	Tablet (dispersible) 20 mg‑120 mg	Oral
Azithromycin	Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15mL	Oral
Atenolol	Oral solution 50 mg in 10 mL, 300 mL	Oral
Captopril	Oral solution 5 mg per mL,  95 mL	Oral
Carbamazepine	Oral suspension 100 mg per 5 mL,  300 mL	Oral
Ciclosporin	Oral liquid 100 mg per mL, 50 mL	Oral
Ciclosporin	Capsule 10 mg	Oral
Ciclosporin	Solution concentrate for I.V. infusion 50 mg in 1 mL	Injection
Ciprofloxacin	Ear drops 3 mg (as hydrochloride) per mL, 5 mL	Application to the ear
Clarithromycin	Powder for oral liquid 250 mg per 5 mL, 50 mL	Oral
Clonazepam	Oral liquid 2.5 mg per mL, 10 mL	Oral
Clonazepam	Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)	Injection
Diazepam	Injection 10 mg in 2mL	Injection
Diazepam	Oral liquid 1 mg in 1 mL, 100 mL	Oral
Diclofenac	Suppository containing diclofenac sodium 100 mg	Rectal
Digoxin	Paediatric oral solution 50 micrograms per mL,  60 mL	Oral
Efavirenz	Oral solution 30 mg per mL, 180 mL	Oral
Escitalopram	Oral solution 20 mg (as oxalate) per mL, 15 mL	Oral
Ethosuximide	Oral solution 250 mg per 5 mL, 200 mL	Oral
Fluconazole	Powder for oral suspension 50 mg in 5 mL, 35 mL	Oral
Furosemide	Oral solution 10 mg per mL, 30 mL	Oral
Glyceryl Trinitrate	Sublingual spray (pump pack) 400 micrograms per dose, 200 doses	Sublingual
Indometacin	Suppository 100 mg	Rectal
Levodopa with carbidopa	Tablet (modified release) 200 mg‑50 mg (as monohydrate)	Oral
Mercaptopurine	Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL	Oral
Methadone	Oral liquid containing methadone hydrochloride 25 mg per 5mL, 200 mL	Oral
Methadone	Injection containing methadone hydrochloride 10 mg in 1 mL	Injection
Metronidazole	Suppositories 500 mg, 10	Rectal
Metronidazole	Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL	Oral
Mycophenolic Acid	Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL	Oral
Naproxen	Oral suspension 125 mg per 5mL, 474 mL	Oral
Nevirapine	Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL	Oral
Ondansetron	Syrup, 4 mg (as hydrochloride dihydrate) per 5 mL, 50mL	Oral
Oxycodone	Oral solution containing oxycodone hydrochloride 1 mg per mL, 250 mL	Oral
Pantoprazole	Sachet containing granules 40 mg (as sodium sesquihydrate)	Oral
Paracetamol	Oral liquid 120 mg per 5 mL, 100 mL	Oral
Paracetamol	Oral liquid 240 mg per 5 mL, 200 mL	Oral
Paracetamol	Suppositories 500 mg, 24	Rectal
Prochlorperazine	Injection containing prochlorperazine mesilate 12.5 mg in 1 mL	Injection
Ranitidine	Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL	Oral
Risperidone	Oral solution 1mg per mL, 100 mL	Oral
Roxithromycin	Tablet for oral suspension 50 mg	Oral
Salbutamol	Oral solution 2 mg (as sulfate) per 5 mL, 150 mL	Oral
Salbutamol	Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth
Terbinafine	Cream containing terbinafine hydrochloride 10 mg per g, 15 g	Application
Tramadol	Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL	Oral
Valganciclovir	Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL	Oral
Valproic Acid	Tablet, crushable, containing sodium valproate 100 mg	Oral
Valproic Acid	Oral liquid containing sodium valproate 200 mg per 5mL, 300 mL	Oral
Valproic Acid	Oral solution containing sodium valproate 200 mg per 5mL, 300 mL	Oral
Voriconazole	Powder for oral suspension 40 mg per mL, 70 mL	Oral

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

Endnote 2—Abbreviation key

ad = added or inserted	o = order(s)
am = amended	Ord = Ordinance
amdt = amendment	orig = original
c = clause(s)	par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x	/sub‑subparagraph(s)
Ch = Chapter(s)	pres = present
def = definition(s)	prev = previous
Dict = Dictionary	(prev…) = previously
disallowed = disallowed by Parliament	Pt = Part(s)
Div = Division(s)	r = regulation(s)/rule(s)
ed = editorial change	reloc = relocated
exp = expires/expired or ceases/ceased to have	renum = renumbered
effect	rep = repealed
F = Federal Register of Legislation	rs = repealed and substituted
gaz = gazette	s = section(s)/subsection(s)
LA = Legislation Act 2003	Sch = Schedule(s)
LIA = Legislative Instruments Act 2003	Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given	SLI = Select Legislative Instrument
effect	SR = Statutory Rules
(md not incorp) = misdescribed amendment	Sub‑Ch = Sub‑Chapter(s)
cannot be given effect	SubPt = Subpart(s)
mod = modified/modification	underlining = whole or part not
No. = Number(s)	commenced or to be commenced

Endnote 3—Legislation history

Name	Registration	Commencement	Application, saving and transitional provisions
PB 81 of 2017	26 Sept 2017 (F2017L01265)	26 Sept 2017 (s 2)
PB 90 of 2017	30 Oct 2017 (F2017L01400)	1 Nov 2017 (s 2)	—
PB 45 of 2018	31 May 2018 (F2018l00694)	1 June 2018 (s 2)	—
PB 61 of 2018	29 June 2018 (F2018L00958)	1 July 2018 (s 2)	—
PB 72 of 2018	1 Aug 2018 (F2018L01074)	1 Aug 2018 (s 2)	—
PB 97 of 2018	26 Oct 2018 (F2018L01484)	1 Nov 2018 (s 2)	—

Endnote 4—Amendment history

Provision affected	How affected
s 2.............................................	rep LA s 48D
s 3.............................................	rep LA s 48C
Schedule
Schedule...................................	am F2017L01400; F2018L00694; F2018L00958; F2018L01074; F2018L01484